CurrentRheuma
Get Weekly

Topic · page 26 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,001–1,040 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Lupus

    Plasma exosomes may mediate the development of lupus nephritis in patients with systemic lupus erythematosus

    Mechanistic study

  2. Lupus Sci Med

    Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis

    Meta-analysis

  3. Rheumatology (Oxford)

    Lymphadenopathy in systemic lupus erythematosus: no microbial trigger found by shotgun metagenomics in a retrospective study on 38 patients

    Cohort study

  4. Semin Arthritis Rheum

    Primary headache in SLE –systematic review and meta-analysis

    Meta-analysis

  5. Semin Arthritis Rheum

    Systematic review of treatments for the gastrointestinal manifestations of systemic lupus erythematosus

    Meta-analysis

  6. Rheumatology (Oxford)

    Impact of baseline proteinuria level on long-term outcomes in lupus nephritis

    Cohort study

  7. Clin Exp Rheumatol

    Self-efficacy is associated with a lower probability of damage accrual in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort

    Cohort study

  8. Rheumatology (Oxford)

    Prevalence and clinical value of autoantibodies directed against lysobisphosphatidic acid in antiphospholipid syndrome

    Cross-sectional study

  9. Arthritis Res Ther

    Oxysterols contribute to immune cell recruitment in SLE skin lesions

    Mechanistic study

  10. Lupus

    Do novel inflammation biomarkers arising from routine complete blood count play a role in patients with systemic lupus erythematosus?

    Cohort study

  11. Arthritis Res Ther

    Predictive biomarkers for low-dose IL-2 therapy efficacy in systemic lupus erythematosus: a clinical analysis

    Cohort study

  12. Rheumatology (Oxford)

    Contributors to organ damage in childhood lupus: corticosteroid use and disease activity

    Cohort study

  13. Ann Rheum Dis

    Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

    Randomized controlled trial

  14. Ann Rheum Dis

    Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations

    Research article

  15. Lupus

    LncRNA NRIR serves as a biomarker for systemic lupus erythematosus and participates in the disease progression

    Diagnostic or prognostic study

  16. Rheumatology (Oxford)

    ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)

    Cross-sectional study

  17. Rheumatology (Oxford)

    Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumab

    Secondary analysis

  18. Arthritis Care Res (Hoboken)

    Association Between 25‐hydroxyvitamin D Levels and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus

    Cohort study

  19. Rheumatology (Oxford)

    Soluble urine activated leukocyte cell adhesion molecule is a strong predictor of lupus nephritis

    Cohort study

  20. Lupus

    Peripheral mononuclear cells and systemic lupus erythematosus association: Integrated study of single-cell sequencing and mendelian randomization analysis

    Mechanistic study

  21. Lupus

    SLE patient satisfaction with care in Jordan: A single-center study

    Cross-sectional study

  22. Lupus Sci Med

    Validating claims-based algorithms for a systemic lupus erythematosus diagnosis in Medicare data for informed use of the Lupus Index: a tool for geospatial research

    Diagnostic or prognostic study

  23. Lupus

    Diving deep into lupus: Gastrointestinal involvement insights from the Oman lupus study

    Cohort study

  24. Lupus

    Evaluating the impact of type 2 diabetes mellitus on interstitial lung disease prevalence in patients with systemic lupus erythematosus: A national inpatient sample analysis

    Cohort study

  25. Clin Exp Rheumatol

    Post-COVID-19 psychological condition in systemic lupus erythematosus patients: a prospective observational study

    Cohort study

  26. Semin Arthritis Rheum

    Development and external validation of a prediction model for interstitial lung disease in systemic lupus erythematosus patients: A cross-sectional study

    Cross-sectional study

  27. Semin Arthritis Rheum

    Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort

    Cohort study

  28. Lupus Sci Med

    Clinical features of Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuritis associated with SLE

    Cohort study

  29. Rheumatology (Oxford)

    A retrospective evaluation of glucagon-like peptide-1 receptor agonists in systemic lupus erythematosus patients

    Cohort study

  30. Rheumatology (Oxford)

    Caffeine improves systemic lupus erythematosus endothelial dysfunction by promoting endothelial progenitor cells survival

    Mechanistic study

  31. Lupus Sci Med

    Methyl-donor supplementation in women with systemic lupus erythematosus with different nutritional status: the protocol for a randomised, double-blind, placebo-controlled trial

    Trial design

  32. Lupus Sci Med

    5-Hydroxymethylcytosine in circulating cell-free DNA as a potential diagnostic biomarker for SLE

    Mechanistic study

  33. Lupus

    Does the standard proteinuria cut-off for renal biopsy in lupus nephritis as per the current guidelines hold good for Asian population? A single-centre study from South India

    Cohort study

  34. Lupus

    Assessment of renal response in Tunisian patients with proliferative lupus nephritis under three different induction immunosuppressive agents: A prognostic retrospective study

    Cohort study

  35. Lupus Sci Med

    Dancing with disorder: chorea – an unusual and neglected manifestation of antiphospholipid syndrome

    Cohort study

  36. Arthritis Care Res (Hoboken)

    Therapeutic Hydroxychloroquine Blood Levels Are Associated With Fewer Hospitalizations and Possible Reduction of Health Disparities in Lupus

    Cohort study

  37. Lupus

    Psychometric properties evaluation of the Persian version of the self-report outcome scale for lupus disease Lupus_PRO version 1.7

    Diagnostic or prognostic study

  38. Ann Rheum Dis

    BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

    Research article

  39. Ann Rheum Dis

    Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology

    Mechanistic study

  40. Arthritis Care Res (Hoboken)

    Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III‐D Report: Multicriteria Decision Analysis

    Guideline or statement

All 1,848 Briefs in ExploreShowing Briefs 1,001–1,040 of 1,848, newest first